Company details


  • Print
  • Share Share
en fr

NicOx specializes in the research and development of nitric oxide-donating compounds intended primarily for the treatment of ophthalmic diseases.The company had a portfolio of three products under clinical development, including one in Phase III (Latanoprostène bunod for treating glaucoma and ocular hypertension).NicOx has strategic partnership with some pharmaceutical and biotech companies among which Bausch + Lomb, Merck & Co. and Ferrer.